Sign In
Buy BGNE
$184.71
+0 (+0%)
At Close: Mar 28, 2025
CAMBRIDGE, Mass. and BEIJING, China, June 12, 2020 -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and.
BeiGene to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
11:30am, Friday, 05'th Jun 2020
CAMBRIDGE, Mass. and BEIJING, China, June 05, 2020 -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and.
BEIJING, China and CAMBRIDGE, Mass., June 03, 2020 -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and.
Phase 3 results comparing tislelizumab plus chemotherapy to chemotherapy alone met its primary endpointCompany to host investor conference call and webcast on ASCO clinical.
CAMBRIDGE, Mass. and BEIJING, China, May 26, 2020 -- CAMBRIDGE, Mass. and BEIJING, China, May 22, 2020-- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage.
Chi-Med, BeiGene Join Forces For Solid Cancer Tumor Treatment
08:04am, Tuesday, 26'th May 2020
Hutchison China MediTech (HCM) and BeiGene (BGNE) have now entered into a clinical collaboration agreement for the treatment of various solid tumor cancers.The collaboration will evaluate the safety,
Chi-Med and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of Surufatinib and Fruquintinib with Tislelizumab
06:00am, Tuesday, 26'th May 2020
– Collaboration to explore multiple solid tumor cancer indications – – Initial development focused on multi-cohort trials in the U.S., Europe, China.
CAMBRIDGE, Mass. and BEIJING, China and PETACH TIKVA, Israel, May 21, 2020 -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on.
BeiGene to Present at the Bernstein 36th Annual Strategic Decisions Conference
11:00am, Wednesday, 20'th May 2020
CAMBRIDGE, Mass. and BEIJING, China, May 20, 2020 -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and.
CAMBRIDGE, Mass., and BEIJING, China, May 15, 2020 -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and.
Growth Stocks Like Amazon And Tesla Share These Key Metrics: Advisor
09:45pm, Thursday, 14'th May 2020
Simon Erickson of 7Investing.com joined the podcast this week to discuss the key metrics he uses to identify power growth stocks like Amazon and Tesla.
CAMBRIDGE, Mass. and BEIJING, China, May 14, 2020 -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and.
BeiGene Reports First Quarter 2020 Financial Results
08:05pm, Monday, 11'th May 2020
CAMBRIDGE, Mass. and BEIJING, China, May 11, 2020 -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and.
Edited Transcript of AMGN earnings conference call or presentation 30-Apr-20 9:30pm GMT
10:54am, Friday, 01'st May 2020
Q1 2020 Amgen Inc Earnings Call
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
11:19am, Thursday, 30'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29)• Arvinas Inc (NASDAQ: ARVN) • Biondvax Pharmaceu
